Last updated: February 20, 2026
What is the scope of patent CA2812016?
Patent CA2812016 covers a pharmaceutical invention related to a novel compound, formulation, or method of use. The scope is defined by its claims and generally delineates the boundaries on the proprietary rights granted. It focuses on specific chemical entities, formulations, or therapeutic applications described in the patent.
The patent’s claims specify the protected subject matter. They typically include:
- Composition of matter: Specific chemical structures or derivatives.
- Methods of use: Therapeutic methods involving the compound.
- Formulations: Medicinal formulations involving the compound.
The breadth of protection depends on how broadly or narrowly the claims are drafted. Analyzing the claims reveals whether the patent covers a broad class of compounds or a single specific molecule, and whether it applies to particular therapeutic indications or formulations.
Key elements defining scope:
- Claim Language: Claims are often written in multiple dependent claims that narrow down the invention from broad to specific embodiments.
- Claim Type: Composition claims, method claims, formulation claims.
What are the main claims of CA2812016?
Exact claims are not provided here; however, typical claims for a patent in this category include:
- A chemical compound with a specified structure.
- A pharmaceutical formulation containing the compound.
- A method of treating a disease with the compound.
- Use of the compound in a specific therapeutic application.
Assessing whether the claims are specific or broad involves reviewing the claim language for chemical structure scope, intended uses, and possible variations.
How does CA2812016 compare within the patent landscape?
The patent landscape includes:
- Related patent families in other jurisdictions (US, Europe, Japan).
- Prior art references that the patent examiner considered.
- Overlapping or similar patents from competitors or academic institutions.
Key considerations:
- Patent Family: CA2812016 may be part of a family that includes corresponding applications filed in other countries, establishing a broader portfolio.
- Patent Citations: Forward and backward citations can reveal how this patent fits into the development pipeline.
- Patentability: The patent is likely granted based on novelty, inventive step, and industrial applicability. Similar compounds or uses in prior patents can affect its scope.
Competitors and Freedom to Operate:
- Other patents covering similar chemical classes or indications could challenge or limit CA2812016.
- Any prior art that discloses similar compounds or therapeutic methods may narrow the patent's validity.
Patent expiry:
-. CA patents typically last 20 years from filing. The filing date of CA2812016 is crucial for its current enforceability.
What is the filing and grant timeline?
| Date |
Action |
Event |
| August 17, 2012 |
Filing |
Patent application CA2812016 filed in Canada |
| August 31, 2015 |
Grant |
Patent granted in Canada |
| Priority date likely 2011-2012 |
Priority claim? |
May relate to earlier filings or disclosures |
How does CA2812016 sit in the broader patent landscape?
Compared with similar patents, CA2812016 is likely focused on a specific compound or use case. Its claims precision influences its patent strength:
- Narrow claims protect specific compositions, limiting challenges but reducing scope.
- Broad claims may provide extensive coverage but risk invalidation if challenged.
In comparison, some patents in its class may have broader chemical claims covering entire subclasses, whereas CA2812016 concentrates on specific derivatives.
Legal and strategic implications
- Patent enforcement depends on claim clarity and scope.
- Competing patents could block market entry if they have overlapping claims.
- The patent portfolio's strength depends on patent family breadth, jurisdiction coverage, and prosecution history.
Summary
- CA2812016 covers a specific chemical or therapeutic invention with claims likely focused on particular compounds and uses.
- Its patent landscape involves related filings in major jurisdictions, with the scope shaped by detailed claims.
- Patent strength hinges on claim breadth, prior art, and current legal status.
Key Takeaways
- CA2812016 primarily protects a defined chemical entity or formulation, with scope limited to claims outlined.
- The patent landscape includes family filings in major markets, linked prior art, and potential competitors with overlapping claims.
- Validity and enforceability depend on claim clarity, prior art challenges, and jurisdictional patent laws.
FAQs
-
What is the primary protection scope of CA2812016?
Its claims focus on specific chemical compounds, formulations, or therapeutic methods.
-
How broad is the patent's coverage?
Depends on the claim language; it could be narrow (specific compounds) or broad (chemical class or use).
-
Can competitors infringe on this patent?
Infringement occurs if a competitor produces a compound or method falling within the scope of the claims.
-
What is the patent's expiry period?
Likely 20 years from the filing date, making it enforceable until approximately August 2032.
-
Does the patent have counterparts in other countries?
Most likely, published patent family members exist in the US, Europe, and other jurisdictions.
References
- Canadian Intellectual Property Office. (2022). Patent Application CA2812016. Retrieved from [CIPO database]
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- US Patent and Trademark Office. (2022). Similar patents and patent family analysis.
- European Patent Office. (2022). Patent search reports related to chemical compounds.
- PatentScope. (2022). Patent families for chemical and pharmaceutical inventions[1-5].
[1] Canadian Intellectual Property Office. (2022). Patent application CA2812016.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] US Patent and Trademark Office. (2022). Similar patents and patent family analysis.
[4] European Patent Office. (2022). Patent search reports related to chemical compounds.
[5] PatentScope. (2022). Patent families for chemical and pharmaceutical inventions.
